A Roadmap for Early Development to Commercial Manufacturing
Summary: A key hurdle for any drug development program is bringing the drug to clinical studies. Astute companies strategize past this milestone and plan for clinical and regulatory success.
Lack of preparation for scale-up activities needed for eventual commercialization can often cause major time delays, increased costs, and a significant amount of rework. In this webcast, industry experts have presented key topics to consider when planning for scale-up of a development program. Real-life examples to illustrate issues that have resulted in ineffective technology transfers—and strategies that can be employed to overcome these issues. Watch the webinar to learn how to avoid common pitfalls in the transfer and scale-up process using an integrated approach.